Prosecution Insights
Prosecution Insights
58 pending office actions • 41 art units • 54 examiners • 0 of 58 (0%) have an AI response strategy ready • 83 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 57 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 57 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (2%) |
| §103 only | 34 (59%) |
| §102 only | 4 (7%) |
| §112 only | 6 (10%) |
| Double-patenting + other | 1 (2%) |
| No statute on record | 12 (21%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FERNANDEZ, KATHERINE L | 3 | 57.6% | +38.1% |
| BUNKER, AMY M | 2 | 29.2% | +46.5% |
| SALVOZA, M FRANCO G | 2 | 69.0% | +29.4% |
| ALBERS, KEVIN S | 1 | 25.0% | +51.0% |
| ORDAZ, CHRISTIAN JOSE | 1 | 64.3% | +100.0% |
| RIOS RUSSO, RAUL J | 1 | 86.7% | +9.0% |
| CARTER, TARA ROSE E | 1 | 80.7% | +9.5% |
| HALVORSON, MARK | 1 | 48.0% | +21.6% |
| HEIN, DEVIN C | 1 | 45.8% | +29.9% |
| BEGEMAN, ANDREW W | 1 | 42.6% | +21.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18660889 | DEVICE AND METHOD FOR MANAGEMENT OF DELAYED CHEST CLOSURE | CARTER, TARA ROSE E | 27d |
| 18757070 | THREE-DIMENSIONAL MICROSTRUCTURE PROVIDING ADDITIONAL CURRENT-CARRYING PATHWAYS FOR SENSORS | RIOS RUSSO, RAUL J | 36d |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17178210 | PRECISION DRUG SCREENING FOR PERSONALIZED CANCER THERAPY | BUNKER, AMY M | 58d overdue |
| 18033002 | COMPOSITIONS FOR AND METHODS OF CO-ANALYZING CHROMATIN STRUCTURE AND FUNCTION ALONG WITH TRANSCRIPTION OUTPUT | BUNKER, AMY M | 23d overdue |
| 18962035 | NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE | ALBERS, KEVIN S | 14d |
| 18438768 | DYNAMIC 129Xe GAS EXCHANGE SPECTROSCOPY | BEGEMAN, ANDREW W | 68d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17957373 | METHODS FOR DETECTING NEUTRALIZING ANTIBODIES | SALVOZA, M FRANCO G | 112d overdue |
| 18629488 | GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA | HALVORSON, MARK | 85d overdue |
| 17178210 | PRECISION DRUG SCREENING FOR PERSONALIZED CANCER THERAPY | BUNKER, AMY M | 58d overdue |
| 18225661 | SYSTEM AND METHOD FOR LARGE FIELD OF VIEW, SINGLE CELL ANALYSIS | FERNANDEZ, KATHERINE L | 42d overdue |
| 17774329 | TREATMENT FOR PRIMARY AND METASTATIC CANCER | SALVOZA, M FRANCO G | 24d overdue |
| 18033002 | COMPOSITIONS FOR AND METHODS OF CO-ANALYZING CHROMATIN STRUCTURE AND FUNCTION ALONG WITH TRANSCRIPTION OUTPUT | BUNKER, AMY M | 23d overdue |
| 18757189 | Compositions and Methods for Safeguarding Plant Immunity Response to Elevated Temperatures | ORDAZ, CHRISTIAN JOSE | 3d overdue |
| 18962035 | NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE | ALBERS, KEVIN S | 14d |
| Art Unit | Apps |
|---|---|
| 3798 | 4 |
| 1684 | 4 |
| 1663 | 3 |
| 1632 | 3 |
| 1637 | 3 |
| 3796 | 2 |
| 1642 | 2 |
| 1672 | 2 |
| 1675 | 2 |
| 1636 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18962035 | NON-INVASIVE ORTHOSIS FOR IMMOBILIZING THE CERVICAL SPINE | ALBERS, KEVIN S | 3786 | §103 | Final Rejection | 14d | Pending | Nov 27, 2024 |
| 18757189 | Compositions and Methods for Safeguarding Plant Immunity Response to Elevated Temperatures | ORDAZ, CHRISTIAN JOSE | 1663 | §103 | Non-Final OA | 3d overdue | Pending | Jun 27, 2024 |
| 18757070 | THREE-DIMENSIONAL MICROSTRUCTURE PROVIDING ADDITIONAL CURRENT-CARRYING PATHWAYS FOR SENSORS | RIOS RUSSO, RAUL J | 2858 | §103 | Non-Final OA | 36d | Pending | Jun 27, 2024 |
| 18660889 | DEVICE AND METHOD FOR MANAGEMENT OF DELAYED CHEST CLOSURE | CARTER, TARA ROSE E | 3773 | §103 | Final Rejection | 27d | Pending | May 10, 2024 |
| 18629488 | GENETIC ALTERATIONS IN ISOCITRATE DEHYDROGENASE AND OTHER GENES IN MALIGNANT GLIOMA | HALVORSON, MARK | 1646 | Other | Non-Final OA | 85d overdue | Pending | Apr 08, 2024 |
| 18609720 | METHODS OF TREATMENT BASED ON PATIENT SPECIFIC CLINICAL TRIAL MODELS AND ASSOCIATED MODELS AND USES | HEIN, DEVIN C | 3686 | §103 | Final Rejection | 14d | Pending | Mar 19, 2024 |
| 18438768 | DYNAMIC 129Xe GAS EXCHANGE SPECTROSCOPY | BEGEMAN, ANDREW W | 3798 | §101 | Non-Final OA | 68d | Pending | Feb 12, 2024 |
| 18578262 | VOLUME REDUCTION SOLIDS TREATMENT SYSTEM | GURTOWSKI, RICHARD C | 1773 | §103 | Non-Final OA | 49d | Pending | Jan 10, 2024 |
| 18559337 | HYDROGEL-COATED ORTHOPEDIC IMPLANTS | NGUYEN, VI X | 3771 | §103 | Non-Final OA | 3d overdue | Pending | Nov 06, 2023 |
| 18558211 | COMBINATION THERAPIES FOR THE TREATMENT OF CANCER | RAO, SAVITHA M | 1691 | §103 | Non-Final OA | 10d overdue | Pending | Oct 31, 2023 |
| 18497368 | ESTIMATING PHARMACOKINETICS OF A CONTRAST MEDIUM THROUGH A CARDIOVASCULAR SYSTEM ANALYTICAL MODEL AND/OR NEURAL NETWORK ALGORITHM | FERNANDEZ, KATHERINE L | 3798 | §103 | Final Rejection | 15d | Pending | Oct 30, 2023 |
| 18288505 | COMPOSITIONS AND METHODS FOR RAPID GENERATION OF MODIFIABLE STABLE CELL LINES | BEHARRY, ZANNA MARIA | 1632 | DPOther | Non-Final OA | 63d | Pending | Oct 26, 2023 |
| 18473202 | COMPOSITIONS AND METHODS FOR ADJUVANT CANCER THERAPEUTICS | MCKOY, QUINCY ANDRE | 1626 | §103 | Non-Final OA | 44d overdue | Pending | Sep 22, 2023 |
| 18360187 | TUMOR IMAGING WITH X-RAYS AND OTHER HIGH ENERGY SOURCES USING AS CONTRAST AGENTS PHOTON-EMITTING PHOSPHORS HAVING THERAPEUTIC PROPERTIES | NGANGA, BONIFACE N | 3797 | Other | Non-Final OA | 89d overdue | Pending | Jul 27, 2023 |
| 18225661 | SYSTEM AND METHOD FOR LARGE FIELD OF VIEW, SINGLE CELL ANALYSIS | FERNANDEZ, KATHERINE L | 3798 | Other | Final Rejection | 42d overdue | Pending | Jul 24, 2023 |
| 18270613 | METHODS FOR TREATMENT OF CANCER USING ABL INHIBITORS AND DRUGS TARGETING THE MEVALONATE PATHWAY | ROMERO, KRISTEN WANG | 1624 | Other | Non-Final OA | 117d overdue | Pending | Jun 30, 2023 |
| 18324941 | NANOFIBER REINFORCEMENT OF ATTACHED HYDROGELS | HAGOPIAN, CASEY SHEA | 1617 | Other | Non-Final OA | 46d overdue | Pending | May 26, 2023 |
| 18312719 | SYSTEMS AND METHODS FOR PROMOTING REMYELINATION WITH FACTORS DERIVED FROM UMBILICAL CORD BLOOD MACROPHAGES | DENT, ALANA HARRIS | 1643 | Other | Non-Final OA | 20d | Pending | May 05, 2023 |
| 18033002 | COMPOSITIONS FOR AND METHODS OF CO-ANALYZING CHROMATIN STRUCTURE AND FUNCTION ALONG WITH TRANSCRIPTION OUTPUT | BUNKER, AMY M | 1684 | §103 | Non-Final OA | 23d overdue | Pending | Apr 20, 2023 |
| 18026088 | METHODS OF DETECTING AND USING BIOMARKERS FOR GLYCOGEN STORAGE DISEASES | FRITCHMAN, REBECCA M | 1758 | §103 | Final Rejection | 50d overdue | Pending | Mar 13, 2023 |
| 18182018 | SYSTEMS AND METHODS FOR PREDICTION AND DESIGN OF NEURAL STIMULATION | PORTER, JR, GARY A | 3796 | §102 | Non-Final OA | 2d overdue | Pending | Mar 10, 2023 |
| 18024091 | METHODS FOR REPROGRAMMING TARGET CELLS | CORDAS, EMILY ANN | 1632 | §103 | Non-Final OA | 27d | Pending | Mar 01, 2023 |
| 18042032 | MICROFLUIDIC ASSAY DEVICE | GIERE, REBECCA M | 1677 | §103 | Final Rejection | — | Pending | Feb 17, 2023 |
| 18107942 | CROSSTALK SUPPRESSION WITH LOCAL CONTROLS | STOFFA, WYATT A | 2881 | §103 | Non-Final OA | 125d overdue | Pending | Feb 09, 2023 |
| 18001884 | ENHANCED CELL SURVIVAL AGAINST BIOTIC AND ABIOTIC STRESSES THROUGH SALICYLICK ACID-INDUCED NPR1 CONDENSATES | MCWILLIAMS, KELSEY LYNN | 1663 | §112 | Non-Final OA | 72d | Pending | Dec 15, 2022 |
| 18080868 | ENDOSCOPIC IMAGING AND PATTERNED STIMULATION AT CELLULAR RESOLUTION | FERNANDEZ, KATHERINE L | 3798 | §103 | Final Rejection | 16d | Pending | Dec 14, 2022 |
| 18007879 | COMPOSITIONS AND METHODS FOR AUGMENTING AUTOLOGOUS FAT GRAFTS | BEANE, RANDALL L | 1654 | §112 | Non-Final OA | 20d | Pending | Dec 02, 2022 |
| 17927575 | COMPOSITIONS AND METHODS FOR SENSITIZING ACUTE MYELOID LEUKEMIAS TO CHEMOTHERAPY | SOROUSH, ALI | 1614 | §103 | Final Rejection | 56d overdue | Pending | Nov 23, 2022 |
| 17992727 | ANTIGEN DISPLAY SYSTEM AND METHODS FOR CHARACTERIZING ANTIBODY RESPONSES | FLINDERS, JEREMY C | 1684 | §102 | Non-Final OA | 51d overdue | Pending | Nov 22, 2022 |
| 18055406 | TUMOR-INTRINSIC NLRP3 INFLAMMASOME SIGNALING PATHWAY AS A GENETIC AND FUNCTIONAL BIOMARKER FOR IMMUNOTHERAPY RESPONSE | AEDER, SEAN E | 1642 | Other | Non-Final OA | 125d overdue | Pending | Nov 14, 2022 |
| 17921338 | TARGETED GENOMIC INTEGRATION TO RESTORE NEUROFIBROMIN CODING SEQUENCE IN NEUROFIBROMATOSIS TYPE 1 (NF1) | BRETZ, COREY LANE | 1635 | §103 | Non-Final OA | 3d overdue | Pending | Oct 25, 2022 |
| 17919997 | COMPOSITIONS AND METHODS FOR FORMATION AND SECRETION OF EXTRACELLULAR VESICLES AND AAV PARTICLES | SIFFORD, JEFFREY MARK | 1671 | §102 | Non-Final OA | 2d overdue | Pending | Oct 19, 2022 |
| 17957373 | METHODS FOR DETECTING NEUTRALIZING ANTIBODIES | SALVOZA, M FRANCO G | 1672 | Other | Non-Final OA | 112d overdue | Pending | Sep 30, 2022 |
| 17914598 | BETA-ARRESTIN COMPOSITIONS AND ASSOCIATED METHODS | MACFARLANE, STACEY NEE | 1675 | §112 | Non-Final OA | 26d | Pending | Sep 26, 2022 |
| 17895280 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MYELIN RELATED AND INFLAMMATION RELATED DISEASES OR DISORDERS | JEAN-LOUIS, SAMIRA JM | 1642 | §103 | Final Rejection | 93d overdue | Pending | Aug 25, 2022 |
| 17819100 | Dynamic control over multiple host proteases in a genetically modifiel microorganism | RAMIREZ, DELIA M | 1652 | §103 | Non-Final OA | 55d | Pending | Aug 11, 2022 |
| 17798868 | COMPLEX STRUCTURES FROM STIMULI-RESPONSIVE PROTEINS | HIBBERT, CATHERINE S | 1658 | §103 | Non-Final OA | 98d overdue | Pending | Aug 10, 2022 |
| 17758480 | COMPOSISTIONS AND METHODS FOR CRISPR ENABLED DNA SYNTHESIS | ZARA, JANE J | 1637 | §112 | Final Rejection | 88d overdue | Pending | Jul 07, 2022 |
| 17758477 | COMPOSITIONS AND METHODS FOR AUTO-INDUCIBLE CELLULAR LYSIS AND NUCLEOTIDE HYDROLYSIS | MONSHIPOURI, MARYAM | 1651 | §103 | Non-Final OA | 45d overdue | Pending | Jul 07, 2022 |
| 17786397 | METHODS AND COMPOSITIONS FOR MONITORING AND DIAGNOSING HEALTHY AND DISEASE STATES | DAUNER, JOSEPH G | 1682 | §103 | Final Rejection | 56d overdue | Pending | Jun 16, 2022 |
| 17782559 | Pudendal Nerve Burst Stimulation for Bladder Control | HADDAD, MOUSSA MAHER | 3796 | Other | Final Rejection | 52d overdue | Pending | Jun 03, 2022 |
| 17749858 | UNIVERSAL LAMP ASSAYS FOR DETECTION OF NUCLEIC ACID TARGETS | LU, FRANK WEI MIN | 1683 | §112 | Non-Final OA | 14d | Pending | May 20, 2022 |
| 17774329 | TREATMENT FOR PRIMARY AND METASTATIC CANCER | SALVOZA, M FRANCO G | 1672 | §103 | Final Rejection | 24d overdue | Pending | May 04, 2022 |
| 17769985 | DEVICES, SYSTEMS, AND METHODS FOR MODULATING TISSUE TEMPERATURE | PAPE, ALYSSA MORGAN | 3794 | — | Final Rejection | 10d overdue | Pending | Apr 18, 2022 |
| 17768454 | PERIPHERALLY INSERTED LEFT VENTRICULAR VENT AND ANTICOAGULATION CATHETER SYSTEM | TAYLOR, MARISSA ENVENESIA | 3783 | §103 | Non-Final OA | 9d | Pending | Apr 12, 2022 |
| 17768152 | LPXH TARGETING COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF MAKING AND USING THE SAME | CHENG, KAREN | 1623 | §102 | Final Rejection | 31d overdue | Pending | Apr 11, 2022 |
| 17766003 | EPIGENETIC MODULATION OF GENOMIC TARGETS TO CONTROL EXPRESSION OF PWS-ASSOCIATED GENES | LIPPOLIS, ALEXANDRA ROSE | 1637 | §103 | Non-Final OA | 77d | Pending | Apr 01, 2022 |
| 17637760 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PATHOLOGICAL PAIN AND ITCH | GRABER, JAMES J | 1631 | §103 | Non-Final OA | 15d | Pending | Feb 23, 2022 |
| 17636750 | COMPOSITIONS AND METHODS FOR IDENTIFYING REGULATORS OF CELL TYPE FATE SPECIFICATION | REGA, KYLE THOMAS | 1636 | Other | Final Rejection | 9d | Pending | Feb 18, 2022 |
| 17633467 | HIGH-THROUGHPUT SCREENING PLATFORM FOR ENGINEERING NEXT-GENERATION GENE THERAPY VECTORS | LAFAVE, ELIZABETH ROSE | 1684 | §103 | Final Rejection | 67d overdue | Pending | Feb 07, 2022 |
| 17616499 | COMPOSITIONS AND METHODS FOR BONE REPAIR AND BONE HEALTH | NGUYEN, NGOC-ANH THI | 1615 | §103 | Final Rejection | 27d | Pending | Dec 03, 2021 |
| 17603329 | CRISPR/CAS-BASED GENOME EDITING COMPOSITION FOR RESTORING DYSTROPHIN FUNCTION | EBBINGHAUS, BRIANA NOEL | 1632 | Other | Non-Final OA | 52d overdue | Pending | Oct 12, 2021 |
| 17494047 | COMPOSITIONS AND METHODS FOR RAPID AND DYNAMIC FLUX CONTROL USING SYNTHETIC METABOLIC VALVES | ZAHORIK, AMANDA MARY | 1636 | §103 | Final Rejection | 21d | Pending | Oct 05, 2021 |
| 17430991 | PRR-Activating and MicroRNA-Inhibiting Molecules and Methods of Using Same | PERSONS, JENNA L | 1637 | §103 | Final Rejection | 89d overdue | Pending | Aug 13, 2021 |
| 17178210 | PRECISION DRUG SCREENING FOR PERSONALIZED CANCER THERAPY | BUNKER, AMY M | 1684 | §112 | Final Rejection | 58d overdue | Pending | Feb 17, 2021 |
| 17265731 | Enhanced Delivery of Drugs and Other Compounds to the Brain and Other Tissues | DONOGHUE, BRITTNEY ERIN | 1675 | §103 | Non-Final OA | 23d overdue | Pending | Feb 03, 2021 |
| 17007994 | CONJUGATED POLYCATIONIC POLYMERS, METHODS OF USING THE SAME AND METHODS OF TREATING AUTOIMMUNE DISEASES, INFECTIOUS DISEASES AND ACUTE RADIATION EXPOSURE | MEJIAS, SAMANTHA LEE | 1618 | §103 | Final Rejection | 71d overdue | Pending | Aug 31, 2020 |
| 16482941 | COMPOSITIONS AND METHODS FOR CONTROLLING GENE EXPRESSION | BOGGS, RUSSELL T | 1663 | §103 | Non-Final OA | 19d overdue | Pending | Aug 01, 2019 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial